Literature DB >> 10906198

The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency.

L F van Dyk1, H W Virgin, S H Speck.   

Abstract

Gamma-2 herpesviruses encode a homolog of mammalian D-type cyclins. The v-cyclin encoded by murine gammaherpesvirus 68 (gammaHV68) induces cell cycle progression and is an oncogene (L. F. van Dyk, J. L. Hess, J. D. Katz, M. Jacoby, S. H. Speck, and H. W. Virgin IV, J. Virol. 73:5110-5122, 1999). However, the role of the pro-proliferative v-cyclins in gamma-2 herpesvirus pathogenesis is not known. Here we report the generation and characterization of a gammaHV68 v-cyclin mutant (v-cyclin.LacZ) that is unable to express a functional v-cyclin protein. Notably, although the gammaHV68 v-cyclin is expressed from an early-late lytic transcript, v-cyclin. LacZ replicated normally in fibroblasts in vitro and during acute infection in the spleen, liver, and lungs in vivo. Moreover, v-cyclin.LacZ exhibited wild-type (wt) virulence in mice with severe combined immunodeficiency. In addition, in a model of gammaHV68-induced chronic disease in mice lacking the gamma interferon receptor (IFNgammaR(-/-)), v-cyclin.LacZ virus was similar to wt gammaHV68 in terms of the incidence of mortality and vasculitis. Further analysis revealed that the frequencies of splenocytes and peritoneal cells harboring the latent gammaHV68 genome in normal and B-cell-deficient mice infected with wt gammaHV68 or v-cyclin.LacZ were very similar. However, v-cyclin.LacZ was significantly compromised in its capacity to reactivate from latency. This phenotype was conclusively mapped to the v-cyclin gene by (i) generating a marker rescue virus (v-cyclin.MR) from the v-cyclin.LacZ mutant, which restored the frequency of cells in which virus reactivated from latency to the levels observed with wt gammaHV68; and (ii) generating a second v-cyclin mutant virus containing a translation stop codon within the v-cyclin gene (v-cyclin.stop), which was compromised in reactivation from latency. These studies demonstrate that despite expression as a lytic cycle gene, the pro-proliferative gammaHV68 v-cyclin is not required for gammaHV68 replication either in vitro or during acute infection in vivo but rather is a critical determinant of reactivation from latency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906198      PMCID: PMC112265          DOI: 10.1128/jvi.74.16.7451-7461.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  Expression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene.

Authors:  A J Sinclair; I Palmero; A Holder; G Peters; P J Farrell
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

2.  The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.

Authors:  M Hollyoake; A Stühler; P Farrell; J Gordon; A Sinclair
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

3.  Virus-encoded cyclin.

Authors:  J U Jung; M Stäger; R C Desrosiers
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

Review 4.  Interactions of the murine gammaherpesvirus with the immune system.

Authors:  A A Nash; N P Sunil-Chandra
Journal:  Curr Opin Immunol       Date:  1994-08       Impact factor: 7.486

5.  Murine herpesvirus 68 is genetically related to the gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri.

Authors:  S Efstathiou; Y M Ho; S Hall; C J Styles; S D Scott; U A Gompels
Journal:  J Gen Virol       Date:  1990-06       Impact factor: 3.891

6.  The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression.

Authors:  L M Schang; A Hossain; C Jones
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.

Authors:  L Arvanitakis; N Yaseen; S Sharma
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

9.  Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.

Authors:  P D Jeffrey; A A Russo; K Polyak; E Gibbs; J Hurwitz; J Massagué; N P Pavletich
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

10.  The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity.

Authors:  W L Fodor; S A Rollins; S Bianco-Caron; R P Rother; E R Guilmette; W V Burton; J C Albrecht; B Fleckenstein; S P Squinto
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  75 in total

1.  Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis.

Authors:  Victor van Berkel; Beth Levine; Sharookh B Kapadia; James E Goldman; Samuel H Speck; Herbert W Virgin
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.

Authors:  Shivaprakash Gangappa; Sharookh B Kapadia; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Effective vaccination against long-term gammaherpesvirus latency.

Authors:  Scott A Tibbetts; J Scott McClellan; Shivaprakash Gangappa; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes.

Authors:  Linda F van Dyk; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency.

Authors:  James Scott McClellan; Scott A Tibbetts; Shivaprakash Gangappa; Kelly A Brett; Herbert W Virgin
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.

Authors:  Rebecca L Sparks-Thissen; Douglas C Braaten; Scott Kreher; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Specific mutation of a gammaherpesvirus-expressed antigen in response to CD8 T cell selection in vivo.

Authors:  Joy Loh; Daniel L Popkin; Lindsay Droit; Douglas C Braaten; Guoyan Zhao; Xin Zhang; Punit Vachharajani; Nancy Myers; Ted H Hansen; Herbert W Virgin
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

9.  The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency.

Authors:  Nathaniel J Moorman; David O Willer; Samuel H Speck
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Identification of an Rta responsive promoter involved in driving gammaHV68 v-cyclin expression during virus replication.

Authors:  Robert D Allen; Mark N DeZalia; Samuel H Speck
Journal:  Virology       Date:  2007-05-02       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.